STOCK TITAN

Leidos Holdings, Inc. - LDOS STOCK NEWS

Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.

Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:

  • National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
  • Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
  • Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
  • Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.

Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:

  • Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
  • MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
  • Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.

Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.

Rhea-AI Summary

Leidos (NYSE: LDOS) has secured a prime contract valued at $149.2 million from the Naval Undersea Warfare Center to provide engineering, technical, and management services for the Naval Array Technical Support Center. This contract, focused on undersea warfare solutions, is indefinite delivery/indefinite quantity with work primarily in Newport, Rhode Island. Leidos will enhance support for the Navy's towed array assets, demonstrating its commitment to innovative technologies and maintaining a competitive edge in undersea operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
-
Rhea-AI Summary

Leidos (NYSE: LDOS) will participate in the Bank of America Global Industrials Conference 2021 on March 17, 2021, at 3:00 p.m. ET. Jim Reagan, Chief Financial Officer, will engage in a fireside chat during the event. An audio webcast of the conference can be accessed via the Leidos Investor Relations website, with a replay available until September 14, 2021. Leidos, a leading science and technology company, reported annual revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
conferences
-
Rhea-AI Summary

Leidos (NYSE: LDOS), a leading technology and engineering company, will join the J.P. Morgan 2021 Virtual Industrials Conference. CEO Roger Krone is set to engage in a 'fireside chat' on March 16, 2021, at 3:40 p.m. ET. Investors can access a live audio webcast on the Leidos Investor Relations website, with a replay available for 30 days post-event. For the fiscal year ended January 1, 2021, Leidos reported revenues of approximately $12.30 billion. For more details, visit www.Leidos.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
conferences
Rhea-AI Summary

Leidos (LDOS) has secured a $22 million project agreement from the Defense Threat Reduction Agency (DTRA) to conduct clinical studies on COVID-19 therapeutics. This cost-plus-fixed-fee agreement spans 24 months and reinforces Leidos' commitment to combat the pandemic. The company will utilize a new clinical trial prototype for real-time data collection, enabling simultaneous studies of drug combinations to enhance treatment outcomes and military readiness. Collaboration with Personal Health Insights, Syneos Health, and SCOPE International aims to optimize trial efficiency and patient safety monitoring.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
clinical trial covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.91%
Tags
none
-
Rhea-AI Summary

Leidos Holdings, Inc. (NYSE: LDOS) announced robust fourth quarter and fiscal year 2020 results, achieving record revenues of $3.25 billion for Q4, up 10.1% year-over-year. The company reported a non-GAAP diluted EPS of $1.63 for the quarter, compared to $1.51 a year earlier. Fiscal year revenues reached $12.30 billion, a 10.8% increase. Notably, Leidos has a backlog of $31.9 billion and plans to acquire Gibbs & Cox, a maritime engineering firm, for $380 million. For 2021, the company expects revenues between $13.7 billion and $14.1 billion, with non-GAAP diluted EPS guidance of $6.15 to $6.45.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.91%
Tags
Rhea-AI Summary

Leidos Holdings, Inc. (NYSE: LDOS) has declared a quarterly cash dividend of $0.34 per share, payable on March 31, 2021. Stockholders of record as of March 15, 2021 will receive this dividend. Leidos, a leading provider of information technology and engineering solutions, reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020. The company plays a crucial role in addressing challenges in defense, intelligence, and health markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
dividends
-
Rhea-AI Summary

Leidos announced that its CEO, Roger A. Krone, was elected to the National Academy of Engineering on February 9, 2021. This prestigious recognition highlights Krone's exceptional technical leadership in engineering and advancements in aerospace and information technology. Membership is granted to individuals with significant achievements in engineering fields. Krone will be inducted on October 3, 2021. Leidos, headquartered in Reston, Virginia, reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
none
-
Rhea-AI Summary

Leidos (NYSE:LDOS) has secured a prime contract valued at $162 million from the Federal Trade Commission (FTC) to continue its work on the Sentinel Network Services (SNS) program. This single-award, firm fixed-price task order includes a one-year base period with nine extension options. The SNS platform facilitates the processing of over 9 million consumer complaints annually, providing law enforcement with real-time data to enhance consumer protection efforts against deceptive practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
none
Rhea-AI Summary

Leidos (NYSE: LDOS), a leading science and technology company, will participate in Citi's 2021 Global Industrials Virtual Conference on February 17, 2021. CFO Jim Reagan is scheduled for a live question and answer session at 1:50 p.m. ET. Interested parties can access the live audio webcast through the Leidos Investor Relations website, where a replay will also be available for one year. In 2020, Leidos reported annual revenues of approximately $11.09 billion and employs around 38,000 individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
conferences

FAQ

What is the current stock price of Leidos Holdings (LDOS)?

The current stock price of Leidos Holdings (LDOS) is $144.81 as of December 20, 2024.

What is the market cap of Leidos Holdings (LDOS)?

The market cap of Leidos Holdings (LDOS) is approximately 19.0B.

What does Leidos Holdings, Inc. do?

Leidos Holdings, Inc. provides technology, engineering, and science solutions in defense, intelligence, civil, and health markets.

Where is Leidos Holdings, Inc. headquartered?

Leidos Holdings, Inc. is headquartered in Reston, Virginia.

How many employees does Leidos have?

Leidos employs approximately 47,000 people.

What are the main business segments of Leidos?

Leidos operates in four main segments: National Security and Digital, Health & Civil, Commercial & International, and Defense Systems.

What were Leidos' revenues for the fiscal year 2023?

Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023.

What is C2IMERA?

C2IMERA is an advanced command and control tool developed by Leidos for the U.S. Air Force.

What is MHS GENESIS?

MHS GENESIS is a federal electronic health record system deployed by Leidos across all Department of Defense garrison facilities.

What recent project has Leidos completed for the Air Force Research Lab?

Leidos successfully completed key reviews for the Mayhem air-breathing hypersonic system for the Air Force Research Lab.

What are the recent financial highlights for Leidos?

For the first quarter of 2024, Leidos reported a record net income margin of 7.1% and revenues of $3.98 billion.

How does Leidos contribute to national security?

Leidos provides advanced technology solutions for defense and intelligence clients, including cybersecurity, logistics, and security operations.

Leidos Holdings, Inc.

NYSE:LDOS

LDOS Rankings

LDOS Stock Data

18.99B
131.91M
1.04%
78.75%
1.43%
Information Technology Services
Services-computer Integrated Systems Design
Link
United States of America
RESTON